Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Norwegian (OSEAX) Biotech Industry Analysis

UpdatedSep 29, 2025
DataAggregated Company Financials
Companies10
  • 7D-1.4%
  • 3M16.4%
  • 1Y-10.1%
  • YTD-3.8%

Over the last 7 days, the Biotech industry has dropped 1.4%, driven by Thor Medical declining 5.6%. The industry has fallen 10% in the last year. Looking forward, earnings are forecast to grow by 46% annually.

Industry Valuation and Performance

Has the Norwegian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 29 Sep 2025NOK 4.6bNOK 611.6m-NOK 517,428,993.47234.9x-8.8x7.5x
Wed, 27 Aug 2025NOK 4.7bNOK 617.2m-NOK 583,886,080.63266.8x-8.1x7.6x
Fri, 25 Jul 2025NOK 4.9bNOK 885.3m-NOK 745,488,655.39209.6x-6.6x5.5x
Sun, 22 Jun 2025NOK 4.8bNOK 885.3m-NOK 745,251,650.83197.3x-6.5x5.5x
Tue, 20 May 2025NOK 5.1bNOK 895.9m-NOK 889,348,797.99193.2x-5.8x5.7x
Thu, 17 Apr 2025NOK 4.7bNOK 521.6m-NOK 1,026,394,831.66114.7x-4.6x9.1x
Sat, 15 Mar 2025NOK 4.8bNOK 521.7m-NOK 1,101,605,061.47119.7x-4.3x9.2x
Mon, 10 Feb 2025NOK 5.1bNOK 457.1m-NOK 1,121,416,201.72154.5x-4.6x11.2x
Wed, 08 Jan 2025NOK 4.7bNOK 457.5m-NOK 1,072,866,848.74160x-4.4x10.3x
Fri, 06 Dec 2024NOK 4.3bNOK 456.3m-NOK 1,062,528,187.90146.8x-4x9.3x
Sun, 03 Nov 2024NOK 4.6bNOK 472.8m-NOK 1,074,585,104.0560.3x-4.3x9.7x
Tue, 01 Oct 2024NOK 5.0bNOK 469.5m-NOK 1,048,902,067.0562.3x-4.8x10.7x
Thu, 29 Aug 2024NOK 6.1bNOK 468.1m-NOK 1,045,668,674.7068.7x-5.8x13x
Sat, 27 Jul 2024NOK 9.1bNOK 517.9m-NOK 1,056,629,205.4771.9x-8.6x17.6x
Mon, 24 Jun 2024NOK 8.9bNOK 641.0m-NOK 938,795,223.8336.6x-9.5x13.9x
Wed, 22 May 2024NOK 8.9bNOK 638.7m-NOK 977,936,959.2133.3x-9.1x13.9x
Fri, 19 Apr 2024NOK 8.2bNOK 661.2m-NOK 951,314,266.6436.2x-8.6x12.4x
Sun, 17 Mar 2024NOK 9.0bNOK 655.4m-NOK 935,914,720.5440.8x-9.6x13.7x
Tue, 13 Feb 2024NOK 15.1bNOK 671.5m-NOK 1,061,859,662.0840.6x-14.3x22.5x
Thu, 11 Jan 2024NOK 16.9bNOK 655.0m-NOK 1,354,915,811.0059.4x-12.5x25.8x
Sat, 09 Dec 2023NOK 15.1bNOK 663.1m-NOK 1,378,416,824.0057.6x-10.9x22.7x
Mon, 06 Nov 2023NOK 13.8bNOK 491.0m-NOK 1,549,505,083.0093x-8.9x28.1x
Wed, 04 Oct 2023NOK 15.1bNOK 626.4m-NOK 1,461,958,476.0053.9x-10.3x24.1x
Fri, 01 Sep 2023NOK 15.9bNOK 627.2m-NOK 1,435,114,831.0060.3x-11.1x25.4x
Sun, 30 Jul 2023NOK 16.3bNOK 555.5m-NOK 1,453,596,890.0058.2x-11.2x29.4x
Tue, 27 Jun 2023NOK 15.1bNOK 561.6m-NOK 1,478,386,871.0057.3x-10.2x26.8x
Thu, 25 May 2023NOK 17.2bNOK 563.1m-NOK 1,498,255,137.0063.9x-11.5x30.6x
Sat, 22 Apr 2023NOK 17.2bNOK 540.4m-NOK 1,450,699,590.0030.8x-11.8x31.8x
Mon, 20 Mar 2023NOK 15.0bNOK 538.6m-NOK 1,566,658,506.0029.5x-9.6x27.8x
Wed, 15 Feb 2023NOK 18.5bNOK 813.3m-NOK 1,414,518,929.0033.5x-13.1x22.8x
Fri, 13 Jan 2023NOK 18.1bNOK 809.7m-NOK 1,394,660,705.0025.2x-13x22.4x
Sun, 11 Dec 2022NOK 20.0bNOK 811.4m-NOK 1,395,546,113.0039.6x-14.3x24.6x
Tue, 08 Nov 2022NOK 17.6bNOK 803.7m-NOK 1,362,079,467.0035.9x-12.9x21.9x
Thu, 06 Oct 2022NOK 17.7bNOK 814.3m-NOK 1,364,923,774.0036.9x-12.9x21.7x
Price to Earnings Ratio

-12.9x


Total Market Cap: NOK 17.7bTotal Earnings: -NOK 1,364,923,774.00Total Revenue: NOK 814.3mTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Biotech Industry Price to Earnings3Y Average -9x202320242025
Current Industry PE
  • Investors are pessimistic on the Norwegian Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 17.6x is higher than the industry's current PS ratio of 7.5x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 9.1% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Norwegian Healthcare industry?

NO Market1.78%
Healthcare-3.48%
Biotech-1.39%
Biotech-1.39%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NYKD Nykode TherapeuticsNOK 1.634.0%
+NOK 20.6m		-64.5%PS6.8x
AZT ArcticZymes TechnologiesNOK 25.601.6%
+NOK 20.4m		43.5%PE466.4x
EXTX EXACT TherapeuticsNOK 2.309.5%
+NOK 12.7m		-60.0%PB2.2x
LYTIX Lytix BiopharmaNOK 7.001.4%
+NOK 6.8m		14.4%PS785.9x

Latest News

AZT
NOK 25.60
ArcticZymes Technologies
7D
1.6%
1Y
43.5%
PCIB
NOK 0.32
PCI Biotech Holding
7D
-0.3%
1Y
-81.7%
HBC
NOK 1.79
Hofseth BioCare
7D
-0.3%
1Y
3.8%
LYTIX
NOK 7.00
Lytix Biopharma
7D
1.4%
1Y
14.4%

Here's Why We're Not Too Worried About Lytix Biopharma's (OB:LYTIX) Cash Burn Situation

Aug 30
Here's Why We're Not Too Worried About Lytix Biopharma's (OB:LYTIX) Cash Burn Situation
ABS
NOK 3.33
Arctic Bioscience
7D
-10.5%
1Y
-74.4%
NYKD
NOK 1.63
Nykode Therapeutics
7D
4.0%
1Y
-64.5%
BGBIO
NOK 1.20
BerGenBio
7D
-3.2%
1Y
-88.1%
EXTX
NOK 2.30
EXACT Therapeutics
7D
9.5%
1Y
-60.0%
TRMED
NOK 3.65
Thor Medical
7D
-5.6%
1Y
140.1%
CRNA
NOK 0.61
Circio Holding
7D
-1.9%
1Y
-9.0%
ZLNA
NOK 12.50
Zelluna
7D
-1.6%
1Y
n/a